Title : Reducing myeloperoxidase activity decreases inflammation and increases cellular protection in ischemic stroke.

Pub. Date : 2019 Sep

PMID : 29673284






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We show that when MPO activity is either blocked by the specific inhibitor 4-aminobenzoic acid hydrazide (ABAH) in wildtype (WT) mice or congenitally absent (MPO-/-), there was decreased cell loss, including degenerating neurons and oligodendrocytes, in the ischemic brains compared to vehicle-treated WT mice after stroke. 4-aminobenzhydrazide myeloperoxidase Mus musculus
2 We show that when MPO activity is either blocked by the specific inhibitor 4-aminobenzoic acid hydrazide (ABAH) in wildtype (WT) mice or congenitally absent (MPO-/-), there was decreased cell loss, including degenerating neurons and oligodendrocytes, in the ischemic brains compared to vehicle-treated WT mice after stroke. 4-aminobenzhydrazide myeloperoxidase Mus musculus
3 We show that when MPO activity is either blocked by the specific inhibitor 4-aminobenzoic acid hydrazide (ABAH) in wildtype (WT) mice or congenitally absent (MPO-/-), there was decreased cell loss, including degenerating neurons and oligodendrocytes, in the ischemic brains compared to vehicle-treated WT mice after stroke. 4-aminobenzhydrazide myeloperoxidase Mus musculus
4 Therefore, MPO inhibition with ABAH or MPO deficiency creates a protective environment that decreased inflammatory cell recruitment and increased expression of survival factors to improve functional outcome. 4-aminobenzhydrazide myeloperoxidase Mus musculus